GlycoDisplay

GlycoDisplay is a Danish biotechnology company specializing in the optimization of therapeutic proteins through advanced glycoengineering. The company utilizes its proprietary cell-based platform to create mammalian cell lines with diverse and controlled glycosylation patterns, allowing for the selection of biologics with improved pharmacological properties. By tailoring glycan structures, GlycoDisplay enhances the efficacy, half-life, and safety of monoclonal antibodies and other recombinant proteins. The company operates through a dual model of internal drug development and strategic partnerships with pharmaceutical companies to improve existing and novel biologics.